98
Views
1
CrossRef citations to date
0
Altmetric
Review

Nobiletin a Biologically Active Phytoconstituent: Systematic Review

ORCID Icon, , ORCID Icon &
Pages 204-211 | Received 03 Nov 2020, Accepted 19 Mar 2021, Published online: 02 Jun 2021
 

Abstract

Nobiletin is an abundant phytoconstituent having multiple pharmacological activities. Various citrus species like orange (Citrus sinensis), lemon (Citrus limon), grapefruit (Citrus paradisi) and tangerine (Citrus tangirina) having flavanones, flavones, flavon aglycon, and Polymethoxyflavones (Nobiletin & Tangeretin). Nobiletin (HMF); Hexamethoxyflavone {2-(3, 4)-dimethoxyphenyl)-5,6,7,8-tetramethoxychromen-4-one}is extracted from non-edible orange peel rich in polymethoxyflavones (PMFs). Many are suggesting Nobiletin as chemo-sensitizing agent induces nuclear retention of tumor suppressor protein and Tyrosinase inhibitor, inhibiting hepatitis B virus replication. It is also proposed that 2-aryl-4H-chromen-4-one derivative may be effective in Chikungunya Virus, and other suggested multiple activities. Citrus species are traditionally used in Ayurveda as immune modulator which is effective in viral disease because of their antioxidant properties. To study the ability as drug of an independent phyto-active Nobiletin (HMF) is under consideration, HMF is lipophilic in nature, its physiochemical properties may by enhanced by increasing water solubility for more bioavailable, and prospective as a therapeutic agent or as broad-spectrum antiviral.

Graphical abstract

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.